Gts Securities LLC Bio N Tech Se Put Options Transaction History

Gts Securities LLC

  • $54.2 Billion
  • Q1 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024
SELL
$88.96 - $112.35 $1.71 Million - $2.16 Million
-19,200 Reduced 24.84%
58,100 $5.36 Million
Q4 2023

Feb 14, 2024
SELL
$90.91 - $112.75 $2.1 Million - $2.6 Million
-23,100 Reduced 23.01%
77,300 $8.16 Million
Q3 2023

Nov 15, 2023
BUY
$98.5 - $125.08 $9.89 Million - $12.6 Million
100,400 New
100,400 $10.9 Million

Others Institutions Holding BNTX

# of Institutions
326
Shares Held
40.4M
Call Options Held
1.31M
Put Options Held
1.37M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $19.1B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email